We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · November 02, 2021

Ticagrelor Monotherapy in Patients at High Bleeding Risk Undergoing PCI

European Heart Journal

 

Additional Info

Disclosure statements are available on the authors' profiles:

European Heart Journal
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR
Eur Heart J 2021 Oct 18;[EPub Ahead of Print], J Escaned, D Cao, U Baber, J Nicolas, S Sartori, Z Zhang, G Dangas, DJ Angiolillo, C Briguori, DJ Cohen, T Collier, D Dudek, M Gibson, R Gil, K Huber, U Kaul, R Kornowski, MW Krucoff, V Kunadian, S Mehta, DJ Moliterno, EM Ohman, KG Oldroyd, G Sardella, SK Sharma, R Shlofmitz, G Weisz, B Witzenbichler, S Pocock, R Mehran

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading